The synthetic ursodeoxycholic acid-derivate BAR501 also increased insulin sensitivity and reduced hepatic steatosis, inflammation and fibrosis in mice with mild steatohepatitis [16,17]. The gene discussed is INS; the disease is Hepatic steatosis.